This study investigates the role of the neurokinin 2 receptor (NK2R) in regulating energy expenditure and feeding behaviors. The researchers aimed to determine whether activating NK2R could simultaneously decrease food intake and increase energy expenditure, offering a dual approach to counteracting cardiometabolic diseases such as obesity and type 2 diabetes.
Activation of NK2R led to a significant decrease in food intake and an increase in energy expenditure in the mouse models. These findings suggest that NK2R could be a viable therapeutic target for treating metabolic diseases by addressing both sides of the energy balance equation.
The study utilized genetically engineered mouse models developed in collaboration with genOway. These models were designed to specifically manipulate NK2R expression in targeted tissues, allowing for precise assessment of NK2R's role in metabolic processes. The technical specifications include tissue-specific promoters driving NK2R expression and the incorporation of reporter genes to facilitate tracking and quantification of receptor activity.
Metabolic diseases, Obesity, Type 2 diabetes, Energy expenditure, Appetite regulation
Knockin, Tissue-specific expression, Reporter gene, Genetic engineering
From model design to experimental results
Featured in 600+ scientific articles
Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions
Generated with biopharma partners and in-house
and guaranteed freedom to operate
Models with certified health status from professional breeders in US and Europe
